Fujita M - Search Results

1

SAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx Protein.

Fujita M, Nomaguchi M, Adachi A, Otsuka M. Fujita M, et al. Front Microbiol. 2012 Aug 10;3:297. doi: 10.3389/fmicb.2012.00297. eCollection 2012. Front Microbiol. 2012. PMID: 22908011 Free PMC article.

2

Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype.

Fujita M, Sakurai A, Yoshida A, Matsumoto S, Miyaura M, Adachi A. Fujita M, et al. Microbes Infect. 2002 May;4(6):621-4. doi: 10.1016/s1286-4579(02)01580-0. Microbes Infect. 2002. PMID: 12048031 Free article.

3

Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.

Fujita M, Matsumoto S, Sakurai A, Doi N, Miyaura M, Yoshida A, Adachi A. Fujita M, et al. Microbes Infect. 2002 Oct;4(12):1203-7. doi: 10.1016/s1286-4579(02)01646-5. Microbes Infect. 2002. PMID: 12467760 Free article.

4

Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.

Fujita M, Sakurai A, Yoshida A, Miyaura M, Koyama AH, Sakai K, Adachi A. Fujita M, et al. J Virol. 2003 Jan;77(2):1626-32. doi: 10.1128/jvi.77.2.1626-1632.2003. J Virol. 2003. PMID: 12502880 Free PMC article.

5

Susceptibility of HVS-immortalized lymphocytic HSC-F cells to various strains and mutants of HIV/SIV.

Fujita M, Yoshida A, Sakurai A, Tatsuki J, Ueno F, Akari H, Adachi A. Fujita M, et al. Int J Mol Med. 2003 May;11(5):641-4. Int J Mol Med. 2003. PMID: 12684704

6

[HIV-1, 2].

Adachi A, Ueno F, Fujita M. Adachi A, et al. Among authors: fujita m. Nihon Rinsho. 2003 Mar;61 Suppl 3:497-502. Nihon Rinsho. 2003. PMID: 12718017 Review. Japanese. No abstract available.

7

Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells.

Ueno F, Shiota H, Miyaura M, Yoshida A, Sakurai A, Tatsuki J, Koyama AH, Akari H, Adachi A, Fujita M. Ueno F, et al. Among authors: fujita m. Microbes Infect. 2003 Apr;5(5):387-95. doi: 10.1016/s1286-4579(03)00042-x. Microbes Infect. 2003. PMID: 12737994 Free article.

8

High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site.

Akari H, Fujita M, Kao S, Khan MA, Shehu-Xhilaga M, Adachi A, Strebel K. Akari H, et al. Among authors: fujita m. J Biol Chem. 2004 Mar 26;279(13):12355-62. doi: 10.1074/jbc.M312426200. Epub 2004 Jan 13. J Biol Chem. 2004. PMID: 14722068 Free article.

9

Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation.

Fujita M, Akari H, Sakurai A, Yoshida A, Chiba T, Tanaka K, Strebel K, Adachi A. Fujita M, et al. Microbes Infect. 2004 Jul;6(9):791-8. doi: 10.1016/j.micinf.2004.04.011. Microbes Infect. 2004. PMID: 15374000 Free article.

10

Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS.

Sakurai A, Jere A, Yoshida A, Yamada T, Iwamoto A, Adachi A, Fujita M. Sakurai A, et al. Among authors: fujita m. Microbes Infect. 2004 Jul;6(9):799-805. doi: 10.1016/j.micinf.2004.04.005. Microbes Infect. 2004. PMID: 15374001 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,374 results

Search Page

Filters